In summary, our study demonstrates that hijacking the activity of FTase and GGTase to modify proteins with alternative prenyl donors is a viable strategy for targeting Rho activity in cells that is effective in blocking the invasive potential of breast carcinoma cells. The gene discussed is RHO; the disease is breast carcinoma.